Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.

× No keyword cloud information.

24 in total

1. Multiple myeloma.

Authors: R M Meyer
Journal: Can Fam Physician Date: 1985-06 Impact factor: 3.275

Review 2. Treatment of multiple myeloma in elderly patients. New developments.

Authors: G J Ossenkoppele
Journal: Drugs Aging Date: 1997-08 Impact factor: 3.923

Review 3. Multiple myeloma: current treatment.

Authors: D Samson
Journal: Postgrad Med J Date: 1994-06 Impact factor: 2.401

4. Severe haemolytic anaemia due to cold anti-'i' antibodies associated with cytomegalovirus infection.

Authors: J M Aguado; J M Castrillo; J Sanz; J Serrano
Journal: Postgrad Med J Date: 1990-05 Impact factor: 2.401

5. Demonstration of serum monoclonal immunoglobulin in a case of non-secretory myeloma by immunoisoelectric focusing.

Authors: T Sheehan; D Sinclair; P Tansey; J R O'Donnell
Journal: J Clin Pathol Date: 1985-07 Impact factor: 3.411

6. Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.

Authors: M R Cooper; A Fefer; J Thompson; D C Case; R Kempf; R Sacher; J Neefe; J Bickers; J H Scarffe; R J Spiegel
Journal: Invest New Drugs Date: 1987 Impact factor: 3.850

7. Controversies in the treatment of plasma cell myeloma.

Authors: D E Bergsagel
Journal: Postgrad Med J Date: 1985-02 Impact factor: 2.401

Review 8. T-cell depleted bone marrow transplantation for plasma cell myeloma. Report of a case and review of the results of BMT for myeloma.

Authors: A B Yehuda; R Or; E Naparstek; S Slavin; A Polliack
Journal: Blut Date: 1988-05

Review 9. Multiple myeloma. New treatment options.

Authors: L Camba; B G Durie
Journal: Drugs Date: 1992-08 Impact factor: 9.546

10. Melphalan-resistant multiple myeloma: results of treatment according to the M-2 protocol.

Authors: B Steinke; F W Busch; C Becherer; P Ostendorf; H D Waller
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333